Chart-Typ:
Zeitraum:
| Johnson & Johnson: New Data Reinforces Efficacy, Sustained Disease Control Of IMAAVY | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced new data from the Phase 3 Vivacity-MG3 study and ongoing open label extension in a broad population of antibody-positive adults with... ► Artikel lesen |
| Johnson & Johnson: IMAAVY (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG) | Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+... ► Artikel lesen |
| Johnson & Johnson Announces CE Mark Approval for the New ETHICON 4000 Stapler | Designed to elevate the surgical experience and deliver reliable staple line integrity across a broad range of tissue thickness1 the ETHICON 4000 Surgical Stapler is certified for use in open and... ► Artikel lesen |
| Moderna, Inc.: Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate | Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat CAMBRIDGE, MA / ACCESS Newswire / April... ► Artikel lesen |
| Moderna, Inc.: Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting | Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on... ► Artikel lesen |
| Moderna, Inc.: Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 | mCOMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's fourth authorized productmCOMBRIAX will be made available in the European Union, subject... ► Artikel lesen |
| Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen |
| Aktien New York: Nahost-Unsicherheit bremst US-Aktienmarkt | NEW YORK (dpa-AFX) - Am US-Aktienmarkt hat ein freundlicher Auftakt am Dienstag nicht lange angehalten. Die wichtigsten Indizes drehten vor dem Hintergrund der nach wie vor offenen Entwicklung des... ► Artikel lesen |
| ROUNDUP/Aktien New York: Freundlicher Start - Nahost bleibt kritisches Thema | NEW YORK (dpa-AFX) - Am US-Aktienmarkt geht es am Dienstag nach dem verhaltenen Wochenauftakt wieder freundlich zu. Im Dow Jones Industrial waren die Kursgewinne am deutlichsten, was unter anderem... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACUTUS MEDICAL INC finden Sie auf Wallstreet Online.